BACKGROUND: Native @entity2548 is one of the important routes for hemodialysis @entity1 because of increased long-term survival and preservation of quality of life. We reported on a single-center experience with using pharmacomechanical thrombolysis for the treatment of thrombosed native @entity2548 . MATERIAL/METHODS: This was a retrospective study of 12 hemodialysis @entity1 (8 males and 4 females) with 14 thrombosed distal forearm Brescia-Cimino radiocephalic @entity292 who were referred for pharmacomechanical thrombolytic treatment in the intervention unit of the Radiology Department, from 1 January 2010 to 30 December 2011. Demographic data, technical success rates, clinical success rates and complications were evaluated. The patency was evaluated by Kaplan-Meier analysis. RESULTS: The technical and clinical success was found in 12 thrombosed @entity292 . Only 3 procedures had minor complications including small amounts of adjacent soft tissue @entity1410 . There were no procedure-related major complications. The primary patency rates at 6 and 12 months were 67% and 50%. The secondary patency rates at 6 and 12 months were 75% and 67%. CONCLUSIONS: Pharmacomechanical thrombolysis is a minimally invasive, effective, durable, and safe procedure for the treatment of thrombosed native @entity2548 . This procedure can be considered as an alternative treatment for @entity292 .

Pharmacomechanical thrombolysis for the treatment of thrombosed native XXXX : a single-center experience.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1410 :: ('MESH:D006406', 'Disease') :: ['hematoma'] @entity2548 :: ('MESH:D001164', 'Disease') :: ['arteriovenous fistula'] @entity292 :: ('MESH:D005402', 'Disease') :: ['fistulas', 'thrombosed dialysis fistulas']
@entity2548 :: (MESH:D001164,Disease) :: ['arteriovenous fistula']
